Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1295404.RAD1sxE6NaHcK5cOAwgKJ_-5meLi0s3AWK3NXNxDbMXck130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1295404.RAD1sxE6NaHcK5cOAwgKJ_-5meLi0s3AWK3NXNxDbMXck130_assertion type Assertion NP1295404.RAD1sxE6NaHcK5cOAwgKJ_-5meLi0s3AWK3NXNxDbMXck130_head.
- NP1295404.RAD1sxE6NaHcK5cOAwgKJ_-5meLi0s3AWK3NXNxDbMXck130_assertion description "[Using this technique we have studied the expression levels of several oncogenes including MYC, SIS, FMS, p53, FOS and RAF in both normal hematopoietic cells and bone marrow (BM) cells obtained from acute myelogenous leukemia (AML) patients at presentation, at relapse and in complete remission (CR).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295404.RAD1sxE6NaHcK5cOAwgKJ_-5meLi0s3AWK3NXNxDbMXck130_provenance.
- NP1295404.RAD1sxE6NaHcK5cOAwgKJ_-5meLi0s3AWK3NXNxDbMXck130_assertion evidence source_evidence_literature NP1295404.RAD1sxE6NaHcK5cOAwgKJ_-5meLi0s3AWK3NXNxDbMXck130_provenance.
- NP1295404.RAD1sxE6NaHcK5cOAwgKJ_-5meLi0s3AWK3NXNxDbMXck130_assertion SIO_000772 2653488 NP1295404.RAD1sxE6NaHcK5cOAwgKJ_-5meLi0s3AWK3NXNxDbMXck130_provenance.
- NP1295404.RAD1sxE6NaHcK5cOAwgKJ_-5meLi0s3AWK3NXNxDbMXck130_assertion wasDerivedFrom befree-2016 NP1295404.RAD1sxE6NaHcK5cOAwgKJ_-5meLi0s3AWK3NXNxDbMXck130_provenance.
- NP1295404.RAD1sxE6NaHcK5cOAwgKJ_-5meLi0s3AWK3NXNxDbMXck130_assertion wasGeneratedBy ECO_0000203 NP1295404.RAD1sxE6NaHcK5cOAwgKJ_-5meLi0s3AWK3NXNxDbMXck130_provenance.